- UTI risk factors defined by Kennelly, M., Thiruchelvam, N., Averbeck, M.A., Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections, Adv Urol., 2019; 2:2019:2757862. Study supported by Coloplast.
- Vasudeva, P. and Madersbacher, H., Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored, Neurourol Urodyn., 2014; 33(1):95-100
- Luja female ensured zero flow stops in 87% of catheterisations & <10 mL residual urine at first flow stop in 83% of catheterisations (RCTs, post-hoc, NCT05841004, n=73, & NCT05814211, n=82). Coloplast Data-on-File, 01/2024. Individual results may vary.
- Min. 50 micro-holes on CH10-16.
- Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, 95% CI: [0.76; 0.93]
- Compared to a conventional eyelet catheter.
- Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, 95% CI: [0.87; 0.99]
- Coloplast Data-on-File, RCT, NCT05814211, n=82. 01/2024.
- Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, p<0.001
- Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, 95% CI:[0.79; 0.95]
- Product design, use and local waste management specifics may limit recyclability.
*Samples available with valid prescription only. Limitations apply.
Prior to use, refer to product labeling for complete product instructions for use, contraindications, warnings and precautions.
Luja female is indicated for use by patients with urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. The product is indicated for female patients only (adults and children of and above the age of 2 years). Available by prescription only. Patients performing self-catheterization should follow the advice of, and direct questions about use of the product to, their medical professional. Apply with caution if the patient produces urine with many particles clearly distinguishable by the naked eye, as it may lead to transient urine retention. Before using the device, carefully read the product labels and information accompanying the device including the instructions for use which contain additional safety information. For single-use only; discard it after use. If you experience symptoms of a urinary tract infection, or are unable to pass the catheter into the bladder, contact your healthcare professional. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider. For further information, call Coloplast Corp. at 1-866-226-6362 and/or consult the company website www.coloplast.us.